Actos (pioglitazone)
ACTOS (pioglitazone) – a thiazolidinedione (TZD) and an agonist for peroxisome proliferator activated receptor (PPAR) gamma commonly used to treat type 2 diabetes mellitus. ACTOS decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. Pioglitazone is not an insulin secretagogue. FDA approved uses: […]